Government says home-grown cancer pill too costly to use

LONDON (Reuters) – Britain's health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country's top cancer research centre, a decision critics said was bad for patients and research. If the draft ruling is upheld after further consultation, Zytiga, which is marketed by Johnson & Johnson, will not be reimbursed on the state-run …

PVH Corp. and The V Foundation for Cancer Research Announce New Neckwear Line Benefiting Cancer Research

PVH Corp. , one of the world’s largest apparel companies, and The V Foundation for Cancer Research, one of the nation’s leading cancer research fundraising organizations, announced a new partnership to offer The V Foundation Neckwear Collection – a line of ties inspired by memorable current and past sports figures.

Research and Markets: Cancer Therapies – Global Strategic Business Report: Immunotherapy, Targeted Therapy, Hormonal …

Research and Markets has announced the addition of the "Cancer Therapies – Global Strategic Business Report" re

Research and Markets: Ovarian Cancer – Pipeline Review, H1 2012

Research and Markets has announced the addition of Global Markets Direct's new report "Ovarian Cancer – Pipeline

Soy isoflavone supplements did not provide breast cancer protections

( American Association for Cancer Research ) Findings suggest the effects of food may be more complex. Adverse effect observed in younger women.

Research and Markets: Triple Analysis: Breast Cancer, Prostate Cancer and Apoptosis

Research and Markets has announced the addition of the "Triple Analysis: Breast Cancer, Prostate Cancer and Ap